07/03/2024 3:46 PM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 6:00 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 7:21 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024 7:22 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024 7:24 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024 7:27 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024 7:29 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
|
05/15/2024 3:16 PM | Panbela Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 3:35 PM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 8:09 AM | Nasdaq Stock Market LLC (Filed by) Panbela Therapeutics (Subject)
| Form 25-NSE | |
04/22/2024 7:02 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 3:31 PM | Panbela Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/17/2024 7:36 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
04/04/2024 3:17 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024 11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
03/29/2024 4:08 PM | Panbela Therapeutics (Filer)
| Form POS AM | |
03/29/2024 4:24 PM | Panbela Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/26/2024 3:15 PM | Panbela Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:12 PM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 5:01 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 7:05 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 7:10 PM | Lind Global Fund II LP (Filed by) Panbela Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 4:24 PM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 6:15 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2024 4:28 PM | Panbela Therapeutics (Filer)
| Form 424B4 | |
01/29/2024 5:21 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/28/2024 11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
01/25/2024 11:22 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/25/2024 7:54 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/22/2024 5:08 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/19/2024 4:20 PM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 3:34 PM | Panbela Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024 11:48 AM | Panbela Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/21/2023 8:25 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 8:25 AM | Panbela Therapeutics (Filer)
| Form DEFA14A | |
12/20/2023 11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
12/21/2023 5:00 AM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 3:30 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
11/13/2023 6:27 PM | GOLDMAN SACHS & CO. LLC (Reporting) GOLDMAN SACHS GROUP INC (Reporting) GOLDMAN SACHS GROUP INC (Reporting) Panbela Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/13/2023 6:29 PM | GOLDMAN SACHS & CO. LLC (Reporting) GOLDMAN SACHS GROUP INC (Reporting) GOLDMAN SACHS GROUP INC (Reporting) Panbela Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get out of cash before the Fed's next meeting (Ad) "How I 6X-ed my wife's 401K in 1 year"
At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8720&Placement=NativeDisplay&Source=NativeDisplay) Click here now to watch this exclusive interview |
11/03/2023 4:24 PM | Panbela Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 4:25 PM | Panbela Therapeutics (Filer)
| Form DEFA14A | |
09/14/2023 3:06 PM | Jacob Jeffrey E. (Reporting) Panbela Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |